The rising interest in novel antidepressants on HN suggests to me that even the wildly comfortable readership of HN is struggling with this era. I have no judg

The rising interest in novel antidepressants on HN suggests to me that even the wildly comfortable readership of HN is struggling with this era. I have no judgment to cast on those who try and enjoy adaptogens, but please think through what the broader pattern means: even those who this system rewards struggle to look the morning in the eye. I don't know what that means, per se, but it suggests that conditions are ripe for some sort of monstrous upending. For if the lucky ones are struggling, who isn't? What would be cool would be some sort of graph over time of trending articles pertaining to depression and anxiety (and other mental health problems.) The sentiment of HN matters simply because our industry is so monstrously important to this century. We are all unwilling --- and often unwitting --- bellweathers, by virtue of our relative affluence, influence and prestige. A 'clean sample', if you will; a demographic that typically does not have other, intersecting problems to make the verniers read funny. Someone please start graphing this before I lose an afternoon to it ;D